Insider and congress filings
HCA Healthcare, Inc. (HCA)
About HCA Healthcare, Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Chief executive
- Samuel N. Hazen
- Employees
- 320,000
- Listed since
- Mar 10, 2011
- Market value
- $91.3B
- Price to earnings
- 14.1
- Earnings per share
- $30.70
- Dividend yield
- 0.71%
Earnings
6 reported quarters · next on Oct 23, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 24, 2026 | $7.59 | $7.56 | $20.2B | $19.8B | EPS in lineRevenue beat |
| Q1 FY2026reported Apr 24, 2026 | $7.15 | $7.12 | $19.1B | $19.1B | EPS in lineRevenue in line |
| Jan 27, 2026 | $8.01 | $7.46 | $19.5B | $19.7B | EPS beatRevenue in line |
| Q3 FY2025reported Oct 24, 2025 | $6.96 | $5.79 | $19.2B | $18.6B | EPS beatRevenue beat |
| Q2 FY2025reported Jul 25, 2025 | $6.84 | $6.29 | $18.6B | $18.5B | EPS beatRevenue in line |
| Q1 FY2025reported Apr 25, 2025 | $6.45 | $5.75 | $18.3B | $18.3B | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 13, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Samuel N. HazenChief Executive Officer | $1.6M | $8.5M | $16.4M | $26.5M |
| Jon M. FosterExecutive Vice President and Chief Operating Officer | $1.0M | $1.9M | $8.0M | $11.0M |
| Michael A. MarksExecutive Vice President and Chief Financial Officer | $983K | $1.8M | $7.6M | $10.4M |
| Michael R. McAleveyExecutive Vice President - Chief Legal and Administrat | $1.0M | $1.3M | $3.4M | $5.7M |
| Michael S. Cuffe, M.D.Executive Vice President and Chief Clinical Officer | $975K | $1.3M | $3.5M | $5.7M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $5.1B | 13,003,600 | -2.7% | 5.84% |
| Vanguard Capital Management LLC | $4.0B | 10,141,708 | -0.4% | 4.55% |
| Sanders Capital, LLC | $3.4B | 8,828,287 | -1.4% | 3.96% |
| State Street Corp | $2.9B | 7,469,035 | -0.9% | 3.35% |
| Wellington Management Group LLP | $1.8B | 4,707,473 | +20.5% | 2.11% |
| Geode Capital Management, LLC | $1.4B | 3,668,008 | -0.7% | 1.65% |
| First Eagle Investment Management, LLC | $1.3B | 3,295,565 | +1.3% | 1.48% |
| Vanguard Portfolio Management LLC | $1.1B | 2,712,828 | -1.6% | 1.22% |
| Morgan Stanley | $1.0B | 2,586,771 | +12.7% | 1.16% |
| Goldman Sachs Group Inc | $960.8M | 2,464,314 | +15.4% | 1.11% |
| Jpmorgan Chase & Co | $896.8M | 2,285,832 | -7.2% | 1.03% |
| Arrowstreet Capital, Limited Partnership | $861.5M | 2,209,485 | +2.0% | 0.99% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
6 filings of 325 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Michael R. McAleveyEVP & Chief Legal & Admin Off. | Sold | 1,694 | $533.37 | $904K | Feb 18, 2026 | 0d |
| Christopher F. WyattSVP & Controller | Sold | 4,000 | $505.00 | $2.0M | Feb 11, 2026 | 1d |
| Jennifer BerresSVP & Chief Human Res. Officer | Sold | 4,010 | $503.00 | $2.0M | Feb 11, 2026 | 1d |
| Samuel N. HazenCEO | Sold · 7 lines | 42,877 | $501.04 | $21.5M | Feb 3, 2026 | 2d |
| Michael S. CuffeEVP and Chief Clinical Officer | Sold | 1,500 | $498.09 | $747K | Feb 3, 2026 | 2d |
| Michael R. McAleveyEVP & Chief Legal & Admin Off. | Sold | 3,892 | $473.79 | $1.8M | Nov 5, 2025 | 0d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in HCA
20 disclosures of 90 on record · median 30d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +13.9%S&P +2.7% · vs S&P 500 +11.1% | Jul 20, 2026 | Aug 7, 2026 | 18d |
| Jared Moskowitz | Stock | Purchase | $1,001 - $15,000 | +8.7%S&P +2.9% · vs S&P 500 +5.8% | Jun 17, 2026 | Jul 26, 2026 | 39d |
| Alan ArmstrongSelfFiled late | Stock | Purchase | $1,001 - $15,000 | -10.6%S&P +20.2% · vs S&P 500 -30.8% | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -0.3%S&P +3.2% · vs S&P 500 -3.4% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -9.8%S&P +20.7% · vs S&P 500 -30.5% | Mar 30, 2026 | Apr 7, 2026 | 8d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | -21.1%S&P +11.6% · vs S&P 500 -32.7% | Feb 17, 2026 | Mar 9, 2026 | 20d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -9.8%S&P +11.3% · vs S&P 500 -21.1% | Oct 27, 2025 | Nov 6, 2025 | 10d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +2.9%S&P +16.1% · vs S&P 500 -13.2% | Sep 11, 2025 | Oct 22, 2025 | 41d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +3.0%S&P +19.4% · vs S&P 500 -16.4% | Aug 19, 2025 | Sep 12, 2025 | 24d |
| Val T. HoyleSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +17.0%S&P +31.1% · vs S&P 500 -14.1% | Oct 29, 2024 | Sep 12, 2025 | 318d |
| Val T. HoyleSpouseFiled late | Stock | Sale | $1,001 - $15,000 | +39.4%S&P +28.1% · vs S&P 500 +11.3% | Dec 27, 2024 | Sep 12, 2025 | 259d |
| Jared MoskowitzDependent child | Stock | Purchase | $1,001 - $15,000 | +7.6%S&P +29.3% · vs S&P 500 -21.8% | May 15, 2025 | Jun 27, 2025 | 43d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +16.9%S&P +35.9% · vs S&P 500 -19.0% | May 7, 2025 | Jun 10, 2025 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +16.9%S&P +35.9% · vs S&P 500 -19.0% | May 7, 2025 | Jun 10, 2025 | 34d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | +28.0%S&P +51.2% · vs S&P 500 -23.2% | Apr 7, 2025 | May 14, 2025 | 37d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +34.8%S&P +36.4% · vs S&P 500 -1.6% | Mar 12, 2025 | Apr 10, 2025 | 29d |
| Robert Bresnahan | Stock | Sale | $1,001 - $15,000 | +26.7%S&P +28.3% · vs S&P 500 -1.6% | Feb 25, 2025 | Mar 27, 2025 | 30d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +26.7%S&P +28.3% · vs S&P 500 -1.6% | Feb 25, 2025 | Mar 6, 2025 | 9d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +35.9%S&P +27.6% · vs S&P 500 +8.3% | Jan 17, 2025 | Feb 6, 2025 | 20d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +32.0%S&P +25.7% · vs S&P 500 +6.3% | Jan 22, 2025 | Feb 6, 2025 | 15d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
5 members · estimate, as of Sep 10, 20265 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Jared Moskowitz | Democrat · House | $15,001 - $50,000 | 0.7% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Jimmy Patronis | Republican · House | $15,001 - $50,000 | 1.6% |
| Robert Bresnahan | Republican · House | $1,001 - $15,000 | 0.1% |
| Cliff Bentz | Republican · House | $1,001 - $15,000 | 0.5% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Michael R. McAleveyEVP & Chief Legal & Admin Off. | Other (see filing) | 7,769 | Aug 26, 2026 |
| Mike A. MarksEVP and CFO | Gift | 3,336 | May 7, 2026 |
| Hugh F. JohnstonDirector | Stock award | 809 | Apr 28, 2026 |
| Michael W. MichelsonDirector | Stock award | 925 | Apr 28, 2026 |
| Wayne Joseph RileyDirector | Stock award | 509 | Apr 28, 2026 |
| Andrea B. SmithDirector | Stock award | 509 | Apr 28, 2026 |
| Thomas F. Frist IIIDirector | Stock award | 1,041 | Apr 28, 2026 |
| William R. FristDirector | Stock award | 809 | Apr 28, 2026 |
| Nancy Ann DeparleDirector | Stock award | 509 | Apr 28, 2026 |
| John ChidseyDirector | Stock award | 809 | Apr 28, 2026 |
| Michael R. McAleveyEVP & Chief Legal & Admin Off. | Tax withholding | 3,306 | Feb 13, 2026 |
| Michael R. McAleveyEVP & Chief Legal & Admin Off. | Option exercise | 5,000 | Feb 13, 2026 |
| Michael S. CuffeEVP and Chief Clinical Officer | Stock award | 9,628 | Feb 10, 2026 |
| Jon M. FosterEVP and COO | Tax withholding | 5,888 | Feb 10, 2026 |
| Jon M. FosterEVP and COO | Stock award | 15,696 | Feb 10, 2026 |
| Samuel N. HazenCEO | Tax withholding | 21,323 | Feb 10, 2026 |
| Samuel N. HazenCEO | Stock award | 54,934 | Feb 10, 2026 |
| Mike A. MarksEVP and CFO | Tax withholding | 1,690 | Feb 10, 2026 |
| Mike A. MarksEVP and CFO | Stock award | 5,026 | Feb 10, 2026 |
| Michael R. McAleveyEVP & Chief Legal & Admin Off. | Tax withholding | 3,006 | Feb 10, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling HCA?
Across the 6 most recent open-market filings shown here, 0 were purchases and 6 were sales.
Which members of Congress have traded HCA?
Ro Khanna, Jared Moskowitz, Alan Armstrong, Lisa C. McClain, Val T. Hoyle, Julie Johnson and others disclosed HCA transactions in the filings shown here.
Which members of Congress hold HCA?
5 members of Congress report a position in HCA in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Jared Moskowitz, Gilbert Ray Cisneros, Jr. and Jimmy Patronis. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is HCA in the S&P 500 or the Nasdaq 100?
HCA Healthcare, Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are HCA trades disclosed?
Insider filings on this page reached the public a median of 1 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 30 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.